Chronic pain, multidisciplinary treatment, cost-effectiveness Chronische pijn, multidisciplinaire behandeling, kosteneffectiviteit
Conditions
Interventions
Intervention group:
The GP’s participating in the multidisciplinary treatment program screen their patients for suitability for this study using the inclusion/exclusion criteria. If a patient is deem
Sponsors
Transcare Groningen, Vrije Universiteit Amsterdam, Vrije Universiteit Brussel
Eligibility
Inclusion criteria
Inclusion criteria: - Chronic pain lasting longer than 6 months - Age between 18 and 70 years - No prior treatment with cognitive behavioral therapy aimed at treating chronic pain-related psychological issues
Exclusion criteria
Exclusion criteria: - Neurological pathology in medical history - Diagnosed with cognitive impairments - Current severe psychiatric problems - Not able to complete the questionnaires - Not able to speak/understand Dutch
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Within the current study, the following outcomes will be measured in both groups (intervention and control) after patients’ have signed the informed consent. Effect study: •Health-related quality of life Health-related Quality of life (HRQoL) will be measured using the RAND-36. The RAND-36 exists of 9 subscales: i.e. physical functioning, social functioning, role limitations (physical problems), role limitations (emotional problems), mental health, pain, general health perception. One item is added to measure health change (Hays, Sherbourne, & Mazel, 2016). The score on the RAND-36 will also be used to determine quality adjusted life years (QALY’s), by applying a scoring algorithm developed by Brazier et al. (2002). This algorithm results in a meaningful health state classification measure, in which respondents can be classified in levels of functioning or limitations. The resulting index, scored from 0.0 to 1.0, can be used in the assessment of the QALY’s. •Intensity and extensiveness of pain Pain intensity will be determined using a Visual Analogue Scale (VAS) ranging from 1 (no pain) to 10 (severe pain) and the extensiveness of the pain will be measured by the Widespread Pain Index (WPI) on which participants can indicate where the pain is located using an illustration of a human body. Economic evaluation Costs will be measured from a societal perspective, including medical costs, absenteeism- and presenteeism costs, unpaid productivity costs and informal healthcare costs using cost questionnaires at baseline and at 3, 6, 9 and 12 months after the intake (intervention group) or registration at a GP (control group). •Medical costs: Health care utilization will be measured using retrospective questionnaires. Using these questionnaires, primary care (e.g. care by a GP, physical therapist), secondary care (e.g. care by an Orthopedic surgeon) as well as drug use will be measured. Health care utilization will be valued using ‘the Dutch Manual of costing’(Hakkaar | — |
Secondary
| Measure | Time frame |
|---|---|
| • Pain catastrophizing Catastrophizing thoughts about the pain will be measured using the Pain Catastrophizing Scale (PCS). The PCS is a self-report scale to measure pain catastrophizing, divided into three subscales; magnification, rumination and helplessness(Sullivan, 2003). • Central sensitization The amount of central sensitization will be measured with the Central Sensitization Index (CSI; validated Dutch version (Kregel et al., 2015). The CSI is a self-report screening questionnaire to identify central sensitivity syndromes (e.g. fibromyalgia (Neblett et al., 2013). Satisfaction Satisfaction with the received treatment will be measured using a shortened version of the CQ-Index Module Pain (Krol, de Boer, Pass, & Rademakers, 2013). | — |
Contacts
Public ContactRinske Bults
Canadalaan 10B
Outcome results
None listed